Square Pharmaceuticals Ltd. reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was BDT 18,329.97 million compared to BDT 16,881.36 million a year ago. Revenue was BDT 15,887.36 million compared to BDT 14,650 million a year ago. Net income was BDT 4,283.04 million compared to BDT 4,569.54 million a year ago. Basic earnings per share from continuing operations was BDT 4.83 compared to BDT 5.15 a year ago.
For the nine months, sales was BDT 55,858.39 million compared to BDT 50,731.2 million a year ago. Revenue was BDT 48,144.07 million compared to BDT 43,722.24 million a year ago. Net income was BDT 14,909.53 million compared to BDT 14,210.55 million a year ago. Basic earnings per share from continuing operations was BDT 16.82 compared to BDT 16.03 a year ago.